Finoriq

Finoriq research workspace

Merck & Co., Inc. (MRK) Insider Transactions & Form 4 Activity

Track insider acquisitions, dispositions, options, RSUs, and Form 4 activity for Merck & Co., Inc. (MRK).

Company Snapshot

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Company
Merck & Co., Inc. (MRK)
Ticker
MRK
Market Cap
$307.7B
Latest Price
$124.57
Industry
Biotech & Pharma

Open company research

Merck & Co., Inc. (MRK) Recent Insider Transactions

Recent market insider transaction records indexed for Merck & Co., Inc. (MRK).

InsiderCodeValueTransaction Date
Guindo ChirfiChief Marketing OfficerS | Disposed-$1.2M2026-02-12
Li Dean YExecutive VP & President, MRLS | Disposed-$1.2M2026-02-10
Guindo ChirfiChief Marketing OfficerS | Disposed-$1.2M2026-02-09
Zachary JenniferEVP, General CounselS | Disposed-$3.1M2026-02-09
Zachary JenniferEVP, General CounselS | Disposed-$6.8M2026-02-09

Live data loads in the app

This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.